nach oben

Erschienen in:

01.03.2018 | Case report

Anti CD19 CAR transduced T cells

Cytokine release syndrome: case report

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

…

Tang X, et al. MVP combined with FC as lymphocyte-depleting chemotherapy before car-t treatment can reduce the incidence of severe cytokine release syndrome for relapsed/refractory all patients with high tumour burden. Blood 130 (Suppl. 1): Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/5041?sso-checked=true [abstract] - China

Titel: Anti CD19 CAR transduced T cells
Cytokine release syndrome: case report
Publikationsdatum: 01.03.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-43864-y